BackBarinthus Biotherapeutics Plc. Overview
Barinthus Biotherapeutics Plc. - ADR

Barinthus Biotherapeutics Plc. Target Price

See how BRNS's target price trends over time vs similar companies.

Get informed when a big investor buys or sells

+ Follow

Share Price

$0.6

Average Target Price

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2025-01-13H.C. WainwrightYi Chen$3400.1% upsideOpen
2024-06-13H.C. WainwrightYi Chen$5733.5% upsideOpen
2024-06-13BarclaysCarter Gould$3400.1% upsideOpen

Barinthus Biotherapeutics Plc. (BRNS) FAQ

Stockcircle tracks target price for Barinthus Biotherapeutics Plc. (BRNS), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Target Price page is built for Barinthus Biotherapeutics Plc.'s historical target price trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use target price as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main BRNS overview so you can move from this figure to the surrounding analysis quickly.